The life sciences industry faces many challenges today. Pressures on pipeline and productivity in research and development. Changing regulatory burdens. Counterfeit products and patent expirations. Timeline erosion from drug discovery through clinical trials to regulatory approvals. To remain profitable and sustain growth, the life sciences industry must transition from a reliance on blockbuster drugs to more targeted and personalized therapeutics.
IBM Life Sciences solutions help you accelerate research and development productivity, speed regulatory compliance and reporting, and build efficiencies into the supply chain and across business processes to help you face today's obstacles.
"Life sciences companies are innovation based at their core and the rapidly changing healthcare ecosystem requires them to not only bring new and innovative treatments to market, but to rethink their internal and external business models." Paul Papas Americas Life Sciences Leader, IBM Global Business Services